Bathi sadurunge mbayar bunga, pajak, lan amortisasi: merck.com (MRK)

Logo grafis merck.com (MRK)

Patent blockbusters in oncology are generating a stream of superprofits, while an active R&D pipeline featuring new vaccines mitigates future risks. The EBITDA confirms this resilience, where the value 19351.18 represents the current figure. Strategic acquisitions and Robert Davis's prudent portfolio management ensure long-term revenue growth for Merck & Co., Inc. (MRK).

Merck & Co., Inc. (MRK) - Bathi operasional EBITDA saka 23.11.2025 nganti 10.11.2026

Merck (MRK) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Rega bursa MSD|MRK - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Nilai pasar Merck|MRK - Nilai Perusahaan
- rincian valuasi buku bisnis:
Ekuitas saben Saham Merck|MRK - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku merck.com|MRK - Aset Agregat Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Merck & Co., Inc.|MRK - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Merck & Co.|MRK - Utang perusahaan|Utang marang nilai buku Merck|MRK - Utang jangka dawa perusahaan|Utang jangka cendhak Merck|Rasio jangkoan perantara merck.com
- indikator bathi lan kelipatan valuasi:
MRK - Bathi resik|Bathi mangsa ngarep Merck & Co., Inc.|MRK - Rasio rega marang bathi|Pangali Forward P/E merck.com|MRK - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Merck|MRK - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Merck|MRK - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan merck.com|MRK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Merck & Co., Inc.
Analisis kabeh metrik perusahaan:MRK - MSD
Barang unggulan Merck

The volume of cash generated is critical for assessing the financial stability of Merck & Co., Inc. (MRK). This indicator captures the actual cash inflow from core operations before taxes and debt obligations. By analyzing the trend of gross operating profit before depreciation, an investor determines the business's ability to maintain liquidity. For Merck & Co., Inc. (MRK), this confirms the efficiency of its scaling: following costly R&D, the mass production of drugs ensures a colossal cash flow. The steady growth of this metric guarantees the operational strength of this global biopharmaceutical behemoth.

Karo sapa Merck & Co., Inc. saingan

Eli Lilly and Co. (LLY) - Bathi sadurunge bunga, pajak, lan amortisasi|ABBV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AZN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NVS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi NVO|AMGN (Amgen Corporation) - Bathi operasional EBITDA|Pfizer Corp (PFE) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sanofi (SNY)|bms.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA GSK (GlaxoSmithKline)|Bathi operasional sadurunge potongan amortisasi Takeda Pharmaceutical Company|TEVA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Dr. Reddy's Labs (RDY) - Bathi operasional sadurunge ngurangi amortisasi|VTRS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi roivant.com (ROIV)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Zai Lab|BHC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA COSM